[go: up one dir, main page]

US3825411A - Reagent and method for bilirubin determination - Google Patents

Reagent and method for bilirubin determination Download PDF

Info

Publication number
US3825411A
US3825411A US00284883A US28488372A US3825411A US 3825411 A US3825411 A US 3825411A US 00284883 A US00284883 A US 00284883A US 28488372 A US28488372 A US 28488372A US 3825411 A US3825411 A US 3825411A
Authority
US
United States
Prior art keywords
acid buffer
reagent
level
percent
maleate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US00284883A
Inventor
L Morin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medico Electronic Inc
Original Assignee
Medico Electronic Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medico Electronic Inc filed Critical Medico Electronic Inc
Priority to US00284883A priority Critical patent/US3825411A/en
Application granted granted Critical
Publication of US3825411A publication Critical patent/US3825411A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • G01N33/728—Bilirubin; including biliverdin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/903—Diazo reactions
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/145555—Hetero-N
    • Y10T436/146666—Bile pigment

Definitions

  • This invention relates to a novel reagent and method for the colorimetric determination of total serum bilirubin; and more particularly, to a novel method for the determination of bilirubin by coupling with a specific diazonium salt, diazotate-N'-butyl-4- methoxymetanilamide at an acid pH.
  • Prior Art second approach suffers from the instability of reagents and requiresthat the diazotized sulfanilic acid be prepared fresh daily;
  • the third approach has heretofore suffered from insensitivity and all methods using stable diazonium salts have been qualitative and semi quantitative at best, rather than quantitative.
  • Another object is to provide a direct methodwithout the need to remove proteins and possible interfering substances.
  • Still another object is to provide a method that utilizes a stable reagent that need not be prepared fresh dail Y t
  • another object is to provide a method that is highly sensitive and specific, yielding quantitative determinations.
  • the preferred diazonium salt is Fast Red PDC. It has further been found that maleic acid is superior as a buffer in such bilirubin determinations to other acids that buffer in the desired pH range of about 0.5 to about 2.5.
  • Such other acid buffers include oxalic acid, trihydroxybenzoic acid, dihydroxy- 2 tartaric acid, citric acid, fumaric acid, succinic acid, hydrochloric acid, sulfuric acid, butyric acid, dichloroacetic acid, hihydroxymalic acid, malonic acid, lactic acid, boric acid, etc.
  • the first embodiment of this invention involves a teagent which is a diazonium salt and maleic acid buffer,
  • the solution having a pH between 0.5 and 2.5.
  • the reagent in a more specific sense, contains 0.01 to 10 gram percent of a diazonium salt 01' Fast Red PDC, and 5 to 50 gram percent of a suitable acid buffer or maleic acid buffer (preferably 22 percent maleic acid buffer).
  • the reagent preferably has a pH of 1.8.
  • This invention is practised by mixing a small sample of biological fluid with a reagent, in a ratio of 1/ to l/ 25.
  • the absorbance is read, using a colorimeter, at an appropriate wavelength or with a suitable color filter. With Fast Red PDC, the absorbance, is read between 490 and 650 nm, preferably at 590 nm.
  • the absorbance is then converted to bilirubin concentration, such conversion can be done by means of preparing a conversion chart from known examples as illustrated in Exam- 7 ple l.
  • the reagent of this invention does not have to be prepared daily and can be in effect freeze-dried for storage of up to one year before use.
  • the method of this invention is highly sensitive and specific, and yields quantitative determination.
  • any suitable colorimeter or spectrophotometer can be used to measure the absorbance.
  • suitable colorimeters are: Coleman, Model 44; Perkin-Elmer, Model 124; the colorimeter disclosed in US. Ser. No. 224,457, applicantsi Raymond W. Kiess and Peter H. Stewart, filed: Feb. I 8, 1972, assignee: Kiess Instruments, Inc., 8768 S. W. 131st Street, Miami, Florida, 33156; and the direct reading colorimeter disclosed in US. Pat. 'No. 3,561,878, inventor: R. W. Kiess.
  • acid buffer means that a salt thereof is included.
  • An example is maleic acid buffer, which includes maleic acid and a salt or ester thereof, e.g., sodium maleate, potassium maleate, barium maleate and lithium maleate.
  • Examples of useful diazonium salts are Fast Red PDC (preferred), Fast Red RC, Fast Red 66, Fast Orange GR, Fast Red B, Fast Orange R, Fast Red TR, Fast Red base AL, Fast Blue B, Fast Red B base, Fast Bordeaux BD, Fast Red GG base, Fast Black B base, Fast Red GL base, Fast Blue base, Fast Red 3 GL base, Fast Blue Red 0 base, Fast Red RL base, Fast Scarlet G base, and fast Scarlet R base.
  • the biological fluids tested can'be those of man or animal.
  • EXAMPLE 2 The reagent is prepared and tubed as in Example 1. A set of standards are prepared as in Example 1, except that they are prepared in pooled human serum. The'test procedure of Example 1 is followed. Again, a stable purple color develops within minutes. The absorbance is'linear in proportion to the bilirubin concentration.
  • EXAMPLE 3 EXAMPLE 4
  • the reagent is prepared into two components.
  • the first component is prepared by dissolving grams of Fast Red PDC in 1 liter of deionized water, dispensing 0.5 ml to a set of ampules, freeze-drying the dye in the ampules, and sealing the ampules under nitrogen.
  • the second component is prepared by dissolving 220 grams of maleic acid in a'liter of deionized water.
  • the two components are stored at room temperature for one year. At the end of a year, 2.5 ml of the second component is added to the tubes of the freeze-dried first component.
  • the reagent is then tested as in Example 2. The results are the same as in Example 2.
  • a reagent for determining total bilirubin in biological fluids comprised of an aqueous solution of Fast Red PDC, which is diazoate-N,-butyl-4- methoxymetanilamide, and an acid buffer, said solution having a pH between 0.5 and 2.5.
  • maleic acid buffer includes maleic acid and a member selected from the group consisting of sodium maleate, potassium maleate, barium maleate, and lithium maleate.
  • a method for determining the total bilirubin in biological fluids which comprises admixing a sample of biological fluid with the reagent of claim 19, the ratio of the biological fluid to the reagent being between 1:100 and 1:25, and determining the concentration of bilirubin by means of measuring the absorbance.
  • a method according to claim 12 wherein the acid buffer is maleic acid buffer.
  • maleic acid buffer includes maleic acid and a member selected from the group consisting of sodium maleate, potassium maleate, barium maleate, and lithium maleate.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

A reagent and method for the determination of total serum bilirubin by coupling of bilirubin with a stable diazonium salt, Fast Red PDC or diazotate-N''-butyl-4-methoxy-metanilamide, at an acid pH is disclosed.

Description

(111 3,825,411 [45] July 23, 1974 REAGENT AND METHOD FOR BILIRUBIN DETERMINATION [75] Inventor: Leo G. Morin, Miami, Fla.
[73] Assignee: Medico Electronic, Inc.,
Indianapolis, Ind.
[22] Filed: Aug. 30, 1972 [21] Appl. No.: 284,883
[52] US. Cl. 23/230 B, 252/408 [51] Int. Cl. G0ln 33/16 [58] Field of Search 23/230 B; 252/408 [56] References Cited UNITED STATES PATENTS 2,854,317 9/1958 Free et al. 23/230 3 5/1970 Green 23/230 B 6/1971 Mast 23/230 B Primary Examiner-R. E. Serwin Attorney, Agent, qr Firm-Christen & Sabol; Virgil H. Marsh [57 ABSTRACT A reagent and method for the determination of total serum bilirubin by coupling of bilirubin with a stable diazonium salt, Fast Red PDC or diazotate-N'-butyl-4- methoxy-metanilamide, at an acid pH is disclosed.
14 Claims, No Drawings BACKGROUND OF THIS INVENTION 1. Field of this Invention This invention relates to a novel reagent and method for the colorimetric determination of total serum bilirubin; and more particularly, to a novel method for the determination of bilirubin by coupling with a specific diazonium salt, diazotate-N'-butyl-4- methoxymetanilamide at an acid pH.
2. Prior Art second approach suffers from the instability of reagents and requiresthat the diazotized sulfanilic acid be prepared fresh daily; The third approach has heretofore suffered from insensitivity and all methods using stable diazonium salts have been qualitative and semi quantitative at best, rather than quantitative. There is a need for a method to determine bilirubin that is specific and not subject to interference, and which utilizes a reagent that is reasonably stable and does not require daily preparation.
BROAD DESCRIPTION OF THIS INVENTION It is the primary objective of this invention to provide a colorimetric method and reagent for the determination of bilirubin. 1
Another object is to provide a direct methodwithout the need to remove proteins and possible interfering substances.
Still another object is to provide a method that utilizes a stable reagent that need not be prepared fresh dail Y t another object is to provide a method that is highly sensitive and specific, yielding quantitative determinations.
It has been found that a low pH (of 0.5 to 2.5, preferably about 1.8) in a solution of high molarity diazonium salts such as Fast Red RC, Fast Red GG, Fast Red B, Fast Red TR, Fast Blue B, Fast Bordeaux BD, etc., couple with bilirubin to give a color change that can be used to assy bilirubin. Of the innumerable diazonium salts tested, Fast Red PDC (diazoate-N'-butyl-4- methoxymetanilamide) proved to have significantly greater sensitivity, specificity, and extinction than the others. In addition, it was found that assays with Fast Red PDC were quantitative and not merely qualitative or semi-quantitative. So the preferred diazonium salt is Fast Red PDC. It has further been found that maleic acid is superior as a buffer in such bilirubin determinations to other acids that buffer in the desired pH range of about 0.5 to about 2.5. Such other acid buffers include oxalic acid, trihydroxybenzoic acid, dihydroxy- 2 tartaric acid, citric acid, fumaric acid, succinic acid, hydrochloric acid, sulfuric acid, butyric acid, dichloroacetic acid, hihydroxymalic acid, malonic acid, lactic acid, boric acid, etc.
The first embodiment of this invention involves a teagent which is a diazonium salt and maleic acid buffer,
the solution having a pH between 0.5 and 2.5.
The reagent, in a more specific sense, contains 0.01 to 10 gram percent of a diazonium salt 01' Fast Red PDC, and 5 to 50 gram percent of a suitable acid buffer or maleic acid buffer (preferably 22 percent maleic acid buffer). The reagent preferably has a pH of 1.8.
This invention is practised by mixing a small sample of biological fluid with a reagent, in a ratio of 1/ to l/ 25. The absorbance is read, using a colorimeter, at an appropriate wavelength or with a suitable color filter. With Fast Red PDC, the absorbance, is read between 490 and 650 nm, preferably at 590 nm. The absorbance is then converted to bilirubin concentration, such conversion can be done by means of preparing a conversion chart from known examples as illustrated in Exam- 7 ple l.
The reagent of this invention does not have to be prepared daily and can be in effect freeze-dried for storage of up to one year before use. The method of this invention is highly sensitive and specific, and yields quantitative determination.
Any suitable colorimeter or spectrophotometer can be used to measure the absorbance. Examples of useful colorimeters are: Coleman, Model 44; Perkin-Elmer, Model 124; the colorimeter disclosed in US. Ser. No. 224,457, applicantsi Raymond W. Kiess and Peter H. Stewart, filed: Feb. I 8, 1972, assignee: Kiess Instruments, Inc., 8768 S. W. 131st Street, Miami, Florida, 33156; and the direct reading colorimeter disclosed in US. Pat. 'No. 3,561,878, inventor: R. W. Kiess.
The term acid buffer, as used herein, means that a salt thereof is included. An example is maleic acid buffer, which includes maleic acid and a salt or ester thereof, e.g., sodium maleate, potassium maleate, barium maleate and lithium maleate.
' Examples of useful diazonium salts are Fast Red PDC (preferred), Fast Red RC, Fast Red 66, Fast Orange GR, Fast Red B, Fast Orange R, Fast Red TR, Fast Red base AL, Fast Blue B, Fast Red B base, Fast Bordeaux BD, Fast Red GG base, Fast Black B base, Fast Red GL base, Fast Blue base, Fast Red 3 GL base, Fast Blue Red 0 base, Fast Red RL base, Fast Scarlet G base, and fast Scarlet R base.
The biological fluids tested can'be those of man or animal.
DETAILED DESCRIPTION OF THIS INVENTION leic acid are added and dissolved, and the reagent is brought with water to 1 liter. To a series of tubes is added 2.5 ml of reagent. A set of standards. are prepared and made to contain 0.1, 0.5, 0.8, 1.0. 204.0,
12.0 and 15.0 mg percent of a specified level of bilirubin. The tubes are incubated at 37 C. for 5 minutes. A stable purple color develops and the absorbance is read at 590 nm using a colorimeter (Coleman Model 44).
EXAMPLE 2 The reagent is prepared and tubed as in Example 1. A set of standards are prepared as in Example 1, except that they are prepared in pooled human serum. The'test procedure of Example 1 is followed. Again, a stable purple color develops within minutes. The absorbance is'linear in proportion to the bilirubin concentration.
EXAMPLE 3 EXAMPLE 4 The reagent is prepared into two components. The first component is prepared by dissolving grams of Fast Red PDC in 1 liter of deionized water, dispensing 0.5 ml to a set of ampules, freeze-drying the dye in the ampules, and sealing the ampules under nitrogen. The second component is prepared by dissolving 220 grams of maleic acid in a'liter of deionized water. The two components are stored at room temperature for one year. At the end of a year, 2.5 ml of the second component is added to the tubes of the freeze-dried first component. The reagent is then tested as in Example 2. The results are the same as in Example 2.
What is claimed is:
l. A reagent for determining total bilirubin in biological fluids comprised of an aqueous solution of Fast Red PDC, which is diazoate-N,-butyl-4- methoxymetanilamide, and an acid buffer, said solution having a pH between 0.5 and 2.5.
2. A reagent according to claim 1 wherein the acid buffer is maleic acid buffer.
' 3. A reagent according to claim 1 wherein the Fast Red PDC is present at a level of 0.01 to 10 gramvpercent.
4. A reagent according to claim 1 whereinthe acid buffer is present at a level of 5 to 50 percent .by weight or volume.
5. A reagent according to claim 1 wherein the Fast Red PDC is present at a level of 0.01 to 10 gram percent, and the acid buffer is present at a level of 5 to 50 percent by weight.
6. A reagent according to claim 5 wherein the acid buffer is maleic acid buffer.
7. A reagent according to claim 6 wherein themaleic acid buffer includes maleic acid and a member selected from the group consisting of sodium maleate, potassium maleate, barium maleate, and lithium maleate.
8. A method for determining the total bilirubin in biological fluids which comprises admixing a sample of biological fluid with the reagent of claim 19, the ratio of the biological fluid to the reagent being between 1:100 and 1:25, and determining the concentration of bilirubin by means of measuring the absorbance.
9. A method according to claim 8 wherein the acid buffer is maleic acid buffer.
10. A method according to claim 8 wherein the Fast Red PDC is present at a level of 0.01 to 10 gram percent.
11. A method according to claim 8 wherein the acid is present at a level of 5 to 50 percent by weight or volume.
12. A method according to claim 8 wherein the Fast Red PDC is present at a level of 0.01 to 10 gram percent, and the acid buffer is present at a level of 5 to 50 percent by weight or volume.
13. A method according to claim 12 wherein the acid buffer is maleic acid buffer.
14. A method according to claim 13 wherein the maleic acid buffer includes maleic acid and a member selected from the group consisting of sodium maleate, potassium maleate, barium maleate, and lithium maleate.

Claims (13)

  1. 2. A reagent according to claim 1 wherein the acid buffer is maleic acid buffer.
  2. 3. A reagent according to claim 1 wherein the Fast Red PDC is present at a level of 0.01 to 10 gram percent.
  3. 4. A reagent according to claim 1 wherein the acid buffer is present at a level of 5 to 50 percent by weight or volume.
  4. 5. A reagent according to claim 1 wherein the Fast Red PDC is present at a level of 0.01 to 10 gram percent, and the acid buffer is present at a level of 5 to 50 percent by weight.
  5. 6. A reagent according to claim 5 wherein the acid buffer is maleic acid buffer.
  6. 7. A reagent according to claim 6 wherein the maleic acid buffer includes maleic acid and a member selected from the group consisting of sodium maleate, potassium maleate, barium maleate, and lithium maleate.
  7. 8. A method for determining the total bilirubin in biological fluids which comprises admixing a sample of biological fluid with the reagent of claim 19, the ratio of the biological fluid to the reagent being between 1:100 and 1:25, and determining the concentration of bilirubin by means of measuring the absorbance.
  8. 9. A method according to claim 8 wherein the acid buffer is maleic acid buffer.
  9. 10. A method according to claim 8 wherein the Fast Red PDC is present at a level of 0.01 to 10 gram percent.
  10. 11. A method according to claim 8 wherein the acid is present at a level of 5 to 50 percent by weight or volume.
  11. 12. A method according to claim 8 wherein the Fast Red PDC is present at a level of 0.01 to 10 gram percent, and the acid buffer is present at a level of 5 to 50 percent by weight or volume.
  12. 13. A method according to claim 12 wherein the acid buffer is maleic acid buffer.
  13. 14. A method according to claim 13 wherein the maleic acid buffer includes maleic acid and a member selected from the group consisting of sodium maleate, potassium maleate, barium maleate, and lithium maleate.
US00284883A 1972-08-30 1972-08-30 Reagent and method for bilirubin determination Expired - Lifetime US3825411A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US00284883A US3825411A (en) 1972-08-30 1972-08-30 Reagent and method for bilirubin determination

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US00284883A US3825411A (en) 1972-08-30 1972-08-30 Reagent and method for bilirubin determination

Publications (1)

Publication Number Publication Date
US3825411A true US3825411A (en) 1974-07-23

Family

ID=23091878

Family Applications (1)

Application Number Title Priority Date Filing Date
US00284883A Expired - Lifetime US3825411A (en) 1972-08-30 1972-08-30 Reagent and method for bilirubin determination

Country Status (1)

Country Link
US (1) US3825411A (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3915649A (en) * 1974-08-14 1975-10-28 American Cyanamid Co Bilirubin test material
US4030885A (en) * 1975-09-11 1977-06-21 Sigma Chemical Company Bilirubin determination
US4078892A (en) * 1975-06-30 1978-03-14 Becton, Dickinson And Company Novel means and method for diagnostic quantitation of serum or plasma bilirubin
US4300905A (en) * 1979-06-28 1981-11-17 Boehringer Mannheim Gmbh Rapid test for ascorbic acid determination
US4548905A (en) * 1984-04-09 1985-10-22 Eastman Kodak Company Reagent composition, dry element and method for determination of total bilirubin
US4892833A (en) * 1982-07-07 1990-01-09 Boehringer Mannheim Gmbh Process and a reagent kit for the determination of direct and total filirubin
CN101122604B (en) * 2007-08-28 2011-08-17 石同才 Reagent kit for determining serum bilirubin by fast blue B method

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2854317A (en) * 1950-08-08 1958-09-30 Miles Lab Method and composition for testing bilirubin in urine
US3511607A (en) * 1967-10-06 1970-05-12 Smithkline Corp Laboratory reagent for assay of total bilirubin
US3585001A (en) * 1969-02-17 1971-06-15 Miles Lab Stabilized test device and process for detecting couplable compounds

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2854317A (en) * 1950-08-08 1958-09-30 Miles Lab Method and composition for testing bilirubin in urine
US3511607A (en) * 1967-10-06 1970-05-12 Smithkline Corp Laboratory reagent for assay of total bilirubin
US3585001A (en) * 1969-02-17 1971-06-15 Miles Lab Stabilized test device and process for detecting couplable compounds

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3915649A (en) * 1974-08-14 1975-10-28 American Cyanamid Co Bilirubin test material
US4078892A (en) * 1975-06-30 1978-03-14 Becton, Dickinson And Company Novel means and method for diagnostic quantitation of serum or plasma bilirubin
US4030885A (en) * 1975-09-11 1977-06-21 Sigma Chemical Company Bilirubin determination
US4300905A (en) * 1979-06-28 1981-11-17 Boehringer Mannheim Gmbh Rapid test for ascorbic acid determination
US4892833A (en) * 1982-07-07 1990-01-09 Boehringer Mannheim Gmbh Process and a reagent kit for the determination of direct and total filirubin
US4548905A (en) * 1984-04-09 1985-10-22 Eastman Kodak Company Reagent composition, dry element and method for determination of total bilirubin
EP0158507A3 (en) * 1984-04-09 1987-11-25 Eastman Kodak Company Reagent composition, dry element and method for determination of total bilirubin
CN101122604B (en) * 2007-08-28 2011-08-17 石同才 Reagent kit for determining serum bilirubin by fast blue B method

Similar Documents

Publication Publication Date Title
US3485587A (en) Protein indicator
Pearlman et al. Detection and measurement of total bilirubin in serum, with use of surfactants as solubilizing agents
Barnes et al. The determination of nitrites
US3964865A (en) Lyophilized human hemoglobin standard for colorimetric determination of total hemoglobin
Steele et al. On excitation of biological substances
CN108680572A (en) A kind of color/fluorescence dual signal visualization quickly the method for detection nitrite and application
CN113834944B (en) Quantum dot fluorescence detection method for folic acid in red blood cells
US3825411A (en) Reagent and method for bilirubin determination
Winsten et al. A rapid micro diazo technique for measuring total bilirubin
Haslewood et al. The estimation of bilirubin in blood plasma
Loomis Rapid microcolorimetric determination of dissolved oxygen
Morin et al. Reduction of ferric phenanthroline—a procedure for determining serum uric acid
US4300905A (en) Rapid test for ascorbic acid determination
US4077772A (en) Method for the determination of hemoglobin in trace amounts
US3000836A (en) Stabilized whole blood standard and method of making the same
US5096812A (en) Assay method for gamma glutamyltransferase (GGT) in liquid blood and dried blood
FUJITA et al. Highly sensitive spectrophotometric determination of human serum albumin with 3', 4', 5', 6'-tetrachlorogallein-molybdenum (VI) complex
Mader et al. Polarographic Determination of Folic Acid
Betheil Fluorometric microdetermination of human serum albumin
SU416969A3 (en)
US3226196A (en) Method of testing urine for pregnancy
CN1648167A (en) Concentrated azo dye solution, a staining kit comprising it, and a method for preparing a protein staining solution
US3642444A (en) Analytical reagent and method for carbohydrate analysis in body fluids
US4030885A (en) Bilirubin determination
Wilson et al. The automated measurement of ascorbic acid in serum and urine